Imreplys
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Imreplys, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: EMA Authorised: Imreplys (sargramostim) — Partner Therapeutics Limited